Lamisil (Terbinafine Hydrochloride)

Terbinafine works by inhibiting the fungal enzyme squalene epoxidase, a crucial step in the synthesis of ergosterol, an essential component of fungal cell membranes. Blocking this enzyme leads to accumulation of toxic squalene and loss of membrane integrity, which ultimately kills the fungal cell while sparing human cells.

The dosing regimen for Lamisil topical is set by the prescribing clinician based on the specific indication, severity of infection, patient age and the formulation used. Typically a thin layer is applied once daily to the affected area for the duration recommended by the prescriber. Patients should not alter the dose without medical advice.

Safety data for topical terbinafine during pregnancy and lactation are limited. The product should only be used if the potential benefit outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified health professional. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their doctor.

To place an order, submit an enquiry on the Lamisil product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lamisil (terbinafine) belongs to the allylamine class, which acts on the squalene epoxidase pathway, whereas many alternatives such as clotrimazole or miconazole are azole antifungals that inhibit lanosterol 14α‑demethylase. Allylamines often achieve faster clinical cure rates for dermatophyte infections and may require shorter treatment courses, but individual response and tolerability vary.

Lamisil topical should be stored at room temperature, ideally below 25 °C. Keep the product in its original container, tightly closed, and protect it from moisture, direct sunlight and extreme heat. Do not freeze the cream, and keep it out of reach of children.

Apply a thin, even layer of Lamisil to the clean, dry skin of the affected area, usually once daily, unless otherwise directed by a healthcare professional. Gently rub the cream in until it disappears, and wash hands after application to avoid accidental contact with eyes or mucous membranes.

Although rare, serious adverse reactions can include severe allergic responses such as swelling, hives, or difficulty breathing, and contact dermatitis with blistering. Systemic toxicity, such as liver enzyme elevation, is extremely uncommon with topical use but should be reported if symptoms like jaundice or unexplained fatigue occur.

Lamisil topical should not be used by individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any component of the formulation. It should also be avoided on broken or inflamed skin unless specifically instructed by a physician. Children under the age recommended by the prescriber should not use the product.